Mark Trudeau
President and Chief Executive Officer
pharmaceutical science
Mallinckrodt
Netherlands
Biography
Mr. Trudeau has been president, chief executive officer and a director since June 2013. In anticipation of Mallinckrodt’s spin transaction with Covidien plc, Mr. Trudeau joined Covidien in February 2012 as a senior vice president and president of its Pharmaceuticals business.
Research Interest
Molecular Pharmaceutics & Organic Process Research
